Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Lee Ainslie Shows His Investing Acumen In Winners And Losers: Stock Picks Up 8.4% in Q1

Page 1 of 2

Lee Ainslie’s Maverick Capital had one excellent quarter. Using the latest 13F filing, the firm achieved returns of 8.4% in its 44 long positions in stocks with a $1 billion market cap or more. Ainslie, a “tiger cub,” is known for his simplistic investing style of being long/short equities while avoiding commodities, currencies, bonds, or derivatives and for the past 7 years, Ainslie has led Maverick Capital to beat the S&P 500 on average by about 6-7 percentage points.

First, why do we even track hedge funds? Equity hedge funds returned just 1.4% in 2014 compared with 11.1% in 2013, and 4.8% in 2012. This is embarrassingly low compared to the SPDR S&P 500 ETF Trust (NYSEARCA:SPY)’s 13.5% gain in 2014, 32.3% gain in 2013, and 16% gain in 2012.

What is going on here? Have the managers lost their touch in picking stocks? The answer is a resounding no and the reason is simply size (see a more detailed explanation here). Our small-cap hedge fund strategy which identifies the best stock picks of the best hedge fund managers returned 28.2% in 2014, 53.2% in 2013, and 33.3% in 2012 (see the details here).


Now here’s how Ainslie led Maverick to outperform.

Hot with Hedge Funds

Maverick scored big with its 2.4 million shares held in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) for a total amount of $347 million. The investment paid off very well as the stock surged 39% in the first three months. Maverick’s Valeant Pharmaceuticals Intl Inc(NYSE:VRX) position accounted for 5.4% of the total portfolio. We mentioned Valeant Pharmaceuticals Intl Inc (NYSE:VRX) back in February as one of the 10 most popular Healthcare stocks among hedge funds. Other fund managers benefiting from its recent run are Jeffrey Ubben, Andreas Halvorsen, and Stephen Mandel.

Bored with Google?

Think the stock of Google Inc (NASDAQ:GOOG) is done appreciating? Ainslie will surely disagree. In fact he might think the company’s growth is just getting started as the stock was one of the new positions in Maverick’s latest filing. He also didn’t tip toe into Google Inc (NASDAQ:GOOG) as it immediately became one of his fund’s top holdings at 5.4% of the firm’s portfolio. As of December 31, 2014, Maverick held 659,237 shares of Google Inc (NASDAQ:GOOG) amounting to a $347 million investment. Google made recent headlines as the company said it plans to transform the TV ad space to behave like internet ads. Further, Morgan Stanley CFO Ruth Porat is also set to leave her company and join Google as the new CFO. Google gained 4.1% in the first quarter of 2015.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!